Lawmakers benefit from taxes generated from biotech, and big pharma companies that are generating massive revenues. Expecting 
LABU ~$50-55 range by mid September.
LABU ~$50-55 range by mid September. 註釋
This is when the highs are tested. I would expect a flat line until December. The profit margin is more of a gamble than can be rationally predicted.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。